Robbins LLP Is Investigating the Officers and Directors of ResMed Inc. (RMD) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of ResMed Inc. (NYSE: RMD) breached their fiduciary duties to shareholders. ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.
ResMed Inc. (RMD) Shareholders Have Legal Options
Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.
Attorney Advertising. Past results do not guarantee a similar outcome.
Resmed Aktie jetzt für 4€ handeln - auf Smartbroker.de